Inhibition of T-type and L-type Ca2+ currents by aranidipine, a novel dihydropyridine Ca2+ antagonist

Citation
H. Masumiya et al., Inhibition of T-type and L-type Ca2+ currents by aranidipine, a novel dihydropyridine Ca2+ antagonist, PHARMACOL, 61(2), 2000, pp. 57-61
Citations number
18
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACOLOGY
ISSN journal
00317012 → ACNP
Volume
61
Issue
2
Year of publication
2000
Pages
57 - 61
Database
ISI
SICI code
0031-7012(2000)61:2<57:IOTALC>2.0.ZU;2-C
Abstract
The effects of aranidipine, a novel dihydropyridine Ca2+ channel antagonist , on membrane currents in guinea pig ventricular myocytes and on action pot entials in rabbit sinoatrial node tissue were examined. In myocytes, aranid ipine (10 nmol/l to 1 mu mol/l) concentration-dependently decreased T-type and L-type Ca2+ currents. Aranidipine (1 mu mol/l) had little effect on Kcurrents. In the sinoatrial node, 0.1 mu mol/l aranidipine increased cycle length, a nd decreased +(V) over dot (max) and the slope of the phase 4 dep olarization. Thus, inhibition of both T-type and L-type Ca2+ currents by ar anidipine may partly explain its potent negative chronotropic activity. Cop yright (C) 2000 S. Karger AG, Basel.